We are live on
!
Find out more
Oric Pharmaceuticals
ORIC
ORIC
82 hedge funds and large institutions have $874M invested in Oric Pharmaceuticals in 2021 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 37 increasing their positions, 14 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
164% more repeat investments, than reductions
Existing positions increased: 37 | Existing positions reduced: 14
100% more first-time investments, than exits
New positions opened: 12 | Existing positions closed: 6
8% more funds holding
Funds holding: 76 → 82 (+6)
6.36% more ownership
Funds ownership: 90.88% → 97.24% (+6.4%)
0% more funds holding in top 10
Funds holding in top 10: 5 → 5 (0)
21% less capital invested
Capital invested by funds: $1.1B → $874M (-$229M)
Holders
82
Holders Change
+6
Holders Change %
+7.89%
% of All Funds
1.44%
Holding in Top 10
5
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.09%
New
12
Increased
37
Reduced
14
Closed
6
Calls
$982K
Puts
–
Net Calls
+$982K
Net Calls Change
+$982K
Top Buyers
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
+$40.6M |
| 2 |
State Street
Boston,
Massachusetts
|
+$31.8M |
| 3 |
Jennison Associates
New York
|
+$19.6M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$12.3M |
| 5 |
Wells Fargo
San Francisco,
California
|
+$11.1M |
Top Sellers
| 1 |
O
OrbiMed
New York
|
-$18.5M |
| 2 |
EC
Euclidean Capital
New York
|
-$12.8M |
| 3 |
SCM
Suvretta Capital Management
New York
|
-$8.56M |
| 4 |
ACM
Asymmetry Capital Management
San Francisco,
California
|
-$2.27M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$1.37M |
